Concepedia

Publication | Closed Access

Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia

26

Citations

33

References

2021

Year

Abstract

The results from this study indicate the potential role of SLCO1B1 rs2306283 as a pharmacogenomic marker to guide and optimize methotrexate treatment for delayed elimination in children with acute lymphoblastic leukemia.

References

YearCitations

Page 1